View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Osimertinib 80 / Pemetrexed 500, Non-Small Cell Lung Cancer, Cycle 5+
Protocol-ID: 2541 V1.0 (Mini), OSIM80/PEME500, NSCLC, C5+Indication(s)
- Lung Carcinoma, Non-Small Cell (non-squamous, EGFR exon 19 deletion mutation, EGFR exon 21 Leu858Arg mutation); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.02.2024